September 13, 2018
Advice from the FinTech Front Lines
On September 10, The Bowdoin Group hosted a panel discussion on “The DNA of Boston FinTech” as part of #BostonFinTechWeek. 100+ executives and senior professionals joined us for the inaugural event for the new DCU FinTech Innovation Center. … Read More
September 4, 2018
Originally written on LinkedIn by Jim Urquhart, Vice President of FinTech at The Bowdoin Group.
The 2018 Boston FinTech Week will bring together Boston’s leading innovators across Financial Services and Technology for 35+ events from September 10-14. Experts will discuss trends, challenges, and opportunities in navigating the city’s rapidly changing FinTech landscape.… Read More
August 28, 2018
Originally written on LinkedIn by Kirk Bukowski, Vice President at The Bowdoin Group.
It’s incredible how the investment ecosystem is booming in both the venture capital and private equity industries. VC firms have invested more capital in U.S. companies in the first half of 2018 than in six of the past ten years.… Read More
August 17, 2018
Originally written on LinkedIn by Dave Melville, Founder and CEO of The Bowdoin Group.
Growing companies consistently grapple with the challenge of when specific C-level executive roles should be added. It’s understandable—there are financial factors, concerns over whether the company will be top heavy, egos to manage, and much more.… Read More
June 21, 2018
On June 12th, The Bowdoin Group and Marsh & McLennan hosted the fourth event in their HR leadership panel series, Building Cultures of Innovation and Accountability, at Bowdoin’s office in Waltham, MA. Karen Walker Beecher, COO of The Bowdoin Group, moderated the discussion, which was framed around two timely topics: the #MeToo movement and pay equity.… Read More
April 25, 2018
Originally written for PharmExec.com by Dave Melville, CEO and Founder at The Bowdoin Group.
Launching a new drug is a pinnacle moment for any pharmaceutical company. In the US, it takes an average of 12 years[i] and $800 million dollars[ii] for a drug to make it into the hands of patients, so the importance of getting the launch right cannot be overstated, especially because organizations only have one shot to make a lasting impression.… Read More
April 18, 2018
Co-authored by Paul Manning, VP, Software at The Bowdoin Group, and Sean Walker, Partner at The Bowdoin Group
In a recent Pulse post, VP Sales, CGO and CCO – What’s the Difference and Which Should I Choose?, we laid out the differences between three critical sales leader roles.… Read More
April 5, 2018
The third installation of The Bowdoin Group and Marsh & McLennan’s HR Panel Series, Building Cultures of Innovation and Accountability, took place on March 29th at Bowdoin’s office in Waltham, MA, and featured four inspirational HR innovators from leading companies in the Boston area. … Read More
April 5, 2018
Originally written on LinkedIn by Jim Urquhart, Vice President, FinTech at Bowdoin.
Last week, The Bowdoin Group, in partnership with venture capital firm Hyperplane, hosted a lively panel discussion about “Transforming Data from a Liability to an Asset” in Cambridge, Massachusetts.… Read More
April 3, 2018
Individuals with chart-topping IQs are the brainpower behind leading organizations, using their intellect to keep businesses ahead of the competition and maximize returns.
Many of our clients hire the brightest minds from elite companies and academic institutions.
While these high IQ individuals can bring tremendous value to their work, they may lack emotional intelligence (EQ). … Read More